WHO has approved Coartem Baby, the first malaria medicine specifically designed for infants under six months. The drug now has WHO prequalification, enabling wider procurement, and comes as sweet cherry-flavoured tablets that can be dissolved in liquids, including breast milk. Notably, malaria caused 6,10,000 deaths globally, with most among children under five in Africa in 2024.